Pain Therapeutics To Enter Opioid Painkiller Market In 2003
Executive Summary
Pain Therapeutics, Inc. expects to enter the narcotic painkiller market with two opioid agonist/low-dose opioid antagonist combinations in 2003.
You may also be interested in...
J&J Procrit Will Rely On New Indications, DTC To Compete With Amgen NESP
Johnson & Johnson is focusing on consumer education and line extensions to position Procrit for impending competition from Amgen's NESP.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials